Lung Cancer Treatment in Azerbaijan 2026 — Keytruda, Tagrisso, Tecentriq

Lung cancer (NSCLC, SCLC, EGFR+, ALK+) is the most common cancer diagnosis in Azerbaijan. Pharmacy Remedy supplies the full first-line and maintenance arsenal — PD-1/PD-L1 inhibitors (Keytruda, Opdivo, Tecentriq, Imfinzi), EGFR TKIs (Tagrisso), ALK inhibitors (Alecensa, Xalkori) — directly from licensed Turkish depots to oncology clinics across Azerbaijan.

First-line treatment drugs

Other conditions